Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Printing, Three-Dimensional | 4 | 2024 | 138 | 1.460 |
Why?
|
| Mammography | 19 | 2023 | 1028 | 1.190 |
Why?
|
| Breast Neoplasms | 21 | 2024 | 16040 | 0.790 |
Why?
|
| Mastectomy | 4 | 2024 | 1569 | 0.630 |
Why?
|
| Triple Negative Breast Neoplasms | 6 | 2023 | 1300 | 0.560 |
Why?
|
| Patient Participation | 1 | 2021 | 478 | 0.550 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 636 | 0.510 |
Why?
|
| Mastectomy, Segmental | 1 | 2019 | 1042 | 0.450 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 1279 | 0.420 |
Why?
|
| Breast | 6 | 2022 | 1361 | 0.410 |
Why?
|
| Carcinoma, Ductal, Breast | 4 | 2021 | 1225 | 0.400 |
Why?
|
| Calcinosis | 5 | 2021 | 437 | 0.400 |
Why?
|
| Breast Diseases | 4 | 2024 | 205 | 0.390 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2024 | 7967 | 0.390 |
Why?
|
| Image-Guided Biopsy | 3 | 2018 | 333 | 0.380 |
Why?
|
| Fibroadenoma | 1 | 2010 | 26 | 0.370 |
Why?
|
| Phyllodes Tumor | 1 | 2010 | 65 | 0.360 |
Why?
|
| Carcinoma, Lobular | 3 | 2021 | 619 | 0.320 |
Why?
|
| Neoadjuvant Therapy | 8 | 2023 | 5127 | 0.270 |
Why?
|
| Ultrasonography, Mammary | 3 | 2018 | 383 | 0.240 |
Why?
|
| Fusobacterium | 1 | 2024 | 12 | 0.240 |
Why?
|
| Radiographic Image Enhancement | 4 | 2011 | 406 | 0.230 |
Why?
|
| Bacteroides | 1 | 2024 | 53 | 0.230 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2021 | 694 | 0.220 |
Why?
|
| Breast Implants | 2 | 2020 | 407 | 0.210 |
Why?
|
| Breast Neoplasms, Male | 2 | 2020 | 231 | 0.200 |
Why?
|
| Multimodal Imaging | 3 | 2024 | 553 | 0.200 |
Why?
|
| Paget's Disease, Mammary | 1 | 2020 | 41 | 0.180 |
Why?
|
| Carcinoma, Papillary | 2 | 2018 | 590 | 0.180 |
Why?
|
| Implant Capsular Contracture | 1 | 2020 | 9 | 0.180 |
Why?
|
| Feces | 1 | 2024 | 815 | 0.180 |
Why?
|
| Patient-Specific Modeling | 1 | 2020 | 30 | 0.180 |
Why?
|
| Feasibility Studies | 3 | 2021 | 2361 | 0.180 |
Why?
|
| Epigastric Arteries | 1 | 2020 | 59 | 0.170 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 340 | 0.160 |
Why?
|
| Spinal Neoplasms | 1 | 2024 | 655 | 0.160 |
Why?
|
| Female | 27 | 2024 | 147100 | 0.160 |
Why?
|
| Perforator Flap | 1 | 2020 | 98 | 0.160 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 258 | 0.150 |
Why?
|
| Prospective Studies | 7 | 2021 | 13305 | 0.150 |
Why?
|
| Follow-Up Studies | 6 | 2021 | 15242 | 0.150 |
Why?
|
| Middle Aged | 16 | 2024 | 89359 | 0.140 |
Why?
|
| Breast Implantation | 1 | 2020 | 242 | 0.140 |
Why?
|
| Guideline Adherence | 1 | 2020 | 653 | 0.130 |
Why?
|
| Adenomyoepithelioma | 1 | 2014 | 9 | 0.120 |
Why?
|
| Prognosis | 4 | 2021 | 22258 | 0.120 |
Why?
|
| Humans | 31 | 2024 | 270194 | 0.120 |
Why?
|
| Adult | 13 | 2024 | 80647 | 0.110 |
Why?
|
| Aged | 12 | 2024 | 72779 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2020 | 1927 | 0.110 |
Why?
|
| Receptors, Androgen | 1 | 2019 | 891 | 0.110 |
Why?
|
| Mammaplasty | 1 | 2020 | 792 | 0.100 |
Why?
|
| Mass Screening | 2 | 2011 | 1569 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 1355 | 0.100 |
Why?
|
| Biomarkers, Tumor | 4 | 2024 | 10594 | 0.090 |
Why?
|
| Contrast Media | 3 | 2022 | 1494 | 0.090 |
Why?
|
| Phantoms, Imaging | 3 | 2011 | 1315 | 0.090 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2014 | 393 | 0.090 |
Why?
|
| Sensitivity and Specificity | 6 | 2018 | 5115 | 0.090 |
Why?
|
| Quality of Life | 1 | 2024 | 4724 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 612 | 0.080 |
Why?
|
| Lymph Nodes | 1 | 2020 | 3038 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 3662 | 0.080 |
Why?
|
| Neoplasm, Residual | 1 | 2014 | 1724 | 0.080 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 13873 | 0.080 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 372 | 0.070 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2022 | 3968 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 2010 | 1395 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 1179 | 0.070 |
Why?
|
| Precancerous Conditions | 2 | 2011 | 1079 | 0.070 |
Why?
|
| Axilla | 2 | 2020 | 922 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 3 | 2020 | 4064 | 0.060 |
Why?
|
| Faecalibacterium | 1 | 2024 | 5 | 0.060 |
Why?
|
| Reproducibility of Results | 5 | 2018 | 6176 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 2024 | 39585 | 0.060 |
Why?
|
| Nipples | 1 | 2024 | 138 | 0.060 |
Why?
|
| Saliva | 1 | 2024 | 239 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2024 | 501 | 0.050 |
Why?
|
| Observer Variation | 2 | 2013 | 712 | 0.040 |
Why?
|
| Dissection | 1 | 2020 | 156 | 0.040 |
Why?
|
| Necrosis | 1 | 2020 | 597 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2020 | 348 | 0.040 |
Why?
|
| ROC Curve | 2 | 2013 | 1209 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 1699 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 16287 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 7697 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 14521 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 2018 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2024 | 953 | 0.030 |
Why?
|
| Biopsy | 1 | 2022 | 3497 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2018 | 699 | 0.030 |
Why?
|
| Cancer Care Facilities | 1 | 2018 | 905 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 1327 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2014 | 567 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2013 | 4860 | 0.030 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2020 | 1450 | 0.030 |
Why?
|
| Surgeons | 1 | 2020 | 560 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 5008 | 0.030 |
Why?
|
| Genomics | 1 | 2023 | 2800 | 0.030 |
Why?
|
| Time Factors | 2 | 2020 | 13256 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2013 | 715 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2018 | 2303 | 0.020 |
Why?
|
| Software | 2 | 2010 | 1326 | 0.020 |
Why?
|
| Biomarkers | 1 | 2022 | 5158 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 2482 | 0.020 |
Why?
|
| Adolescent | 1 | 2010 | 32385 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 732 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 866 | 0.020 |
Why?
|
| Radiology Information Systems | 1 | 2010 | 117 | 0.020 |
Why?
|
| Child | 1 | 2010 | 30264 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 4939 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 1348 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2008 | 53 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2011 | 452 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 30764 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 5934 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 1095 | 0.020 |
Why?
|
| Mammary Glands, Human | 1 | 2008 | 184 | 0.020 |
Why?
|
| Texas | 1 | 2018 | 6455 | 0.020 |
Why?
|
| Male | 3 | 2024 | 127386 | 0.020 |
Why?
|
| Radiographic Magnification | 1 | 2005 | 14 | 0.020 |
Why?
|
| Young Adult | 2 | 2014 | 22201 | 0.020 |
Why?
|
| Calcium Carbonate | 1 | 2005 | 28 | 0.020 |
Why?
|
| X-Ray Intensifying Screens | 1 | 2005 | 33 | 0.020 |
Why?
|
| X-Rays | 1 | 2005 | 148 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 3831 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 2008 | 1024 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 9038 | 0.010 |
Why?
|
| United States | 1 | 2020 | 16283 | 0.010 |
Why?
|
| Decision Making | 1 | 2010 | 1341 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2010 | 1367 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 3247 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 34263 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 3968 | 0.010 |
Why?
|